Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
Pancreatic cancer has one of the poorest prognoses among all cancers partly because of its silent nature and tendency for late discovery but also because of its persistent resistance to chemotherapy. At present there are very limited treatment alternatives for pancreatic cancer, hence the need to de...
| Main Authors: | Falasca, Marco, Selvaggi, F., Buus, R., Sulpizio, S., Edling, C. |
|---|---|
| Format: | Journal Article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/12069 |
Similar Items
Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)
by: Edling, C., et al.
Published: (2010)
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014)
by: Edling, C., et al.
Published: (2014)
Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms
by: Fyffe, C., et al.
Published: (2013)
by: Fyffe, C., et al.
Published: (2013)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)
by: Fyffe, C., et al.
Published: (2013)
Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)
by: Mazza, S., et al.
Published: (2013)
Class II Phosphoinositide 3-Kinases as Novel Drug Targets
by: Falasca, Marco, et al.
Published: (2017)
by: Falasca, Marco, et al.
Published: (2017)
Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic ß cells
by: Dominguez, V., et al.
Published: (2011)
by: Dominguez, V., et al.
Published: (2011)
Novel roles for class II Phosphoinositide 3-Kinase C2ß in signalling pathways involved in prostate cancer cell invasion.
by: Mavrommati, I., et al.
Published: (2016)
by: Mavrommati, I., et al.
Published: (2016)
Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.
by: Chikh, A., et al.
Published: (2016)
by: Chikh, A., et al.
Published: (2016)
Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)
by: Falasca, Marco, et al.
Published: (2012)
New insight into the intracellular roles of class II phosphoinositide 3-kinases
by: Maffucci, T., et al.
Published: (2014)
by: Maffucci, T., et al.
Published: (2014)
Phosphoinositides signalling in cancer: Focus on PI3K and PLC
by: Raimondi, C., et al.
Published: (2012)
by: Raimondi, C., et al.
Published: (2012)
Elucidation of the WNT & AKT/Phosphoinositide-3-Kinase Pathways in Colorectal Carcinoma
by: Khor, Tin Oo
Published: (2004)
by: Khor, Tin Oo
Published: (2004)
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation
by: Maffucci, T., et al.
Published: (2009)
by: Maffucci, T., et al.
Published: (2009)
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
by: Tibolla, G., et al.
Published: (2013)
by: Tibolla, G., et al.
Published: (2013)
Analysis, regulation, and roles of endosomal phosphoinositides
by: Maffucci, T., et al.
Published: (2014)
by: Maffucci, T., et al.
Published: (2014)
PITPs as targets for selectively interfering with phosphoinositide signaling in cells
by: Nile, A., et al.
Published: (2014)
by: Nile, A., et al.
Published: (2014)
THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE
by: Tibolla, G., et al.
Published: (2011)
by: Tibolla, G., et al.
Published: (2011)
The extracellular signal-regulated kinase (ERK) pathway: a potential therapeutic target in hypertension
by: Roberts, Richard E.
Published: (2012)
by: Roberts, Richard E.
Published: (2012)
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)
by: Elaskalani, O., et al.
Published: (2017)
Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)
by: Casari, I., et al.
Published: (2015)
ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
by: Adamska, A., et al.
Published: (2018)
by: Adamska, A., et al.
Published: (2018)
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)
by: Adamska, Aleksandra, et al.
Published: (2018)
Molecular targets of colorectal cancer: an insight on intracellular cellular signaling pathways
by: Pandurangan, Ashok Kumar, et al.
Published: (2014)
by: Pandurangan, Ashok Kumar, et al.
Published: (2014)
Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
by: Castresana, Javier S., et al.
Published: (2017)
by: Castresana, Javier S., et al.
Published: (2017)
Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)
by: Falasca, Marco, et al.
Published: (2016)
Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)
by: Ferro, R., et al.
Published: (2014)
Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)
by: Alhadyan, Khaled
Published: (2019)
Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
by: Yip, Wai Kien, et al.
Published: (2013)
by: Yip, Wai Kien, et al.
Published: (2013)
Development of a novel azaspirane that targets the Janus Kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
by: Mohan, C., et al.
Published: (2014)
by: Mohan, C., et al.
Published: (2014)
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, R., et al.
Published: (2018)
by: Ferro, R., et al.
Published: (2018)
Selective targeting of cancer signaling pathways with nanomedicines: challenges and progress
by: Abul Barkat, Harshita, et al.
Published: (2020)
by: Abul Barkat, Harshita, et al.
Published: (2020)
Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)
by: Adamska, A., et al.
Published: (2017)
The Mak2 MAP kinase signal transduction pathway is required for pathogenicity in Stagonospora nodorum
by: Solomon, P., et al.
Published: (2005)
by: Solomon, P., et al.
Published: (2005)
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, Riccardo, et al.
Published: (2018)
by: Ferro, Riccardo, et al.
Published: (2018)
Targeted RNAi of the mitogen-activated protein kinase pathway
genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)
by: Mohd Hafiz, M.R., et al.
Published: (2013)
Targeting PDK1 in cancer
by: Raimondi, C., et al.
Published: (2011)
by: Raimondi, C., et al.
Published: (2011)
Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)
Role of the Hedgehog pathway in the pancreatic tumour microenvironment
by: Saini, Francesca
Published: (2014)
by: Saini, Francesca
Published: (2014)
Similar Items
-
Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010) -
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014) -
Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms
by: Fyffe, C., et al.
Published: (2013) -
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011) -
3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)